About Us

Beijing Strong Biotechnologies, Inc. (hereinafter referred to as BSBE) is a Chinese leading provider of in-vitro diagnostics (IVD) products and service.

BSBE was established in 2001, focusing on R&D, manufacturing and sales of IVD products which reach to international advanced level. BSBE was registered in Beijing, the capital of China with the registered capital of RMB501,787,943 and successfully listed on GEM in Shenzhen with the stock code 300406 in 2014.

As a Chinese leader in IVD filed, BSBE is engaged in developing the best IVD testing platform. And till now, BSBE has the system of clinical biochemistry testing, coagulation testing and blood typing. Due to the steady progression and rich experience in the years, BSBE has a worldwide sales and marketing network.

BSBE is focused on the R&D of IVD products and it has a high qualified R&D team. Under the guidance of the experts, BSBE has established clinical biochemistry platform of enzymatic method (including enzymatic cycling method), immunoturbidimetric method, latex immunoturbidimetric method, CEDIA method, EMIT method; Meanwhile, BSBE has very strong R&D team on liquid coagulation reagents. In 2018, BSBE launches its blood typing system using the DG Gel card technology.

BSBE is engaged to enter the market which efficiently type patients and identify donor match. BSBE is also a co-investigator and manufacturer of national reference material of CysC and it’s the supporter of 863 Projects. The BSBE’s R&D center is “Beijing engineering laboratory for clinical biochemistry and immuno assay reagents”.

In order to meet the need of rapid development, BSBE establishes international advanced production environment and management procedure. BSBE is firmly committed to our mission of “Quality first”, and provides high qualified testings covering clinical biochemistry and serology. BSBE can also provide diversified clinical diagnosis solutions to customers. Meanwhile, BSBE devotes itself to provide friendly experience of end-users and it has after-service team all over the country which can guarantee to solve the problems at the earliest time and professional technical support.

“Running with giants”. Since 2013, BSBE has signed the strategic cooperation agreement with international and domestic well-known enterprises, e.g: Abbott, Roche, Hitachi, Mindray and Weigo. Through more than 10 years of rapid development, BSBE becomes Chinese leading manufacturer and provider of IVD products, and an important player of international IVD market.

“Loyalty, Integrity, Passion” is BSBE’s creed. Now, BSBE becomes the leader of Chinese IVD market, and makes best efforts to provide better products and services to the worldwide.

Corporate Culture


Our Creed

Our Motto

12 Core Standards of Top Employees


Beijing Strong Biotechnologies, Inc. (hereinafter referred to as BSBE) is the trademark of the company and it has two brands-GCELL, Beijing MDC.


GCELL is a brand which focused on IVD since 2002. Due to more than 10 years rapid development, GCELL’s sales network covers the whole China, especially 3A hospitals in China. Meanwhile, the quality is highly recommended by the overseas and domestic customers.

Till now, GCELL has the full range of clinical biochemistry and blood typing with more than 100 testings registered. And some of them are selected “the National Key Products”, “China Torch Program”, “Beijing Self Innovation Products” and obtain the patents.

In recent years, BSBE is engaged to invest on R&D, production, sales and after-service and positions GCELL image as “Good quality”, “Perfect service”, “


Beijing MDC is the brand of BSBE focused on coagulation.

Beijing MDC is a professional provider of coagulation products, and it deals with TECO business in China. In order to meet the demand of customers, Beijing MDC established its own R&D team and develops liquid coagulation reagents which recommended by Chinese customers and sold to the overseas market. Beijing MDC coagulation products with high quality, cost effective and perfect after-service has good reputation among hospitals, pharmaceuticals and institutions in 31 provinces in China. 

Since May, 2017, Beijing MDC becomes the member of BSBE family, this completes coagulation system and provides better service to customers.

BSBE Squamous Cell Carcinoma Antigen Assay